1241 An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
https://www.nature.com/articles/s41586-020-2537-9
1240 cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.
https://www.nature.com/articles/s41586-020-2611-3
1239 Potently neutralizing and protective human antibodies against SARS-CoV-2.
https://www.nature.com/articles/s41586-020-2548-6
1238 A safeguard mechanism protects cells against aberrant immune responses toward their own genomic DNA.
https://science.sciencemag.org/content/369/6505/823
1237 Structures of human CD20 in complexes with therapeutic antibodies reveal molecular mechanisms underlying cancer immunotherapies.
https://science.sciencemag.org/content/369/6505/793
1236 Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function.
https://www.pnas.org/content/117/30/17727
1235 An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity.
https://www.cell.com/immunity/fulltext/S1074-7613(20)30268-5
1234 Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
https://www.cell.com/immunity/fulltext/S1074-7613(20)30231-4
1233 Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells.
https://www.cell.com/cell/fulltext/S0092-8674(20)30620-6
1232 Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
https://www.cell.com/cell/fulltext/S0092-8674(20)30627-9
|
